Biosign Technologies Statement on Recent Market Activity

TORONTO, April 21 /CNW/ - Biosign Technologies Inc. (TSX-V: BIO; "Biosign"), issues the following statement as a result of unusual stock activity in trading of the company's common shares:

Other than a news release issued by Biosign on April 19, 2011, announcing the departures of a director and the Chief Executive Officer, the company is not aware of any corporate developments outside of the ordinary course of business that might explain the stock activity.

About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit www.biosign.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Biosign Technologies Inc.

For further information:

Contact

Radu Leca, President & CEO
Biosign Technologies Inc.
Phone: (416) 218-9800 ext. 234
Email: ceo@biosign.com
          Alan S. Roemer, SVP
The Trout Group LLC
Phone: 646 378-2945
E-mail: aroemer@troutgroup.com

 

Organization Profile

Biosign Technologies Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890